AIM AND SCOPE
Journal of Metabolic Disorders and Diabetes (JMDD) aims at rapid publication of high quality results in Metabolic Disorders and Diabetes while maintaining rigorous peer-review process. All accepted papers will be appearing online immediately.
JMDD encourages submission of manuscripts related to (but not limited to) Insulin Dependent Diabetes Mellitus, Impaired Glucose Tolerance, Diabetic Drugs, Diabetic Complications, Diabetic Retinopathy, Genetics of Diabetes Areas:
- Bone and Mineral Metabolism
- Diabetes induced Infertility
- Diabetic Complications
- Gestational Diabetes
- Hormone Metabolism
- Impaired Glucose Tolerance
- Stereochemistry of insulin
- Insulin Resistance
Publication of article types:
Original research articles: Describes original research within the scope of the journal.
Case reports: Reports of clinical presentations describing a diagnostic or therapeutic dilemma followed by evaluative studies
Editorial comments: Introduce current research and comment on major advances and developments in the field.
Methodology: Present a new experimental method, test or procedure. The methods described may be completely new or a better version of already existing one. The method should demonstrate all the possible tests and results.
Rapid communications: Short papers presenting highly significant and original material.
Review articles: To review the progression of a research in the field and make suggestions for future work includes authoritative, comprehensive, descriptions of any subject within the scope of Metabolic Disorders & Diabetes journal.
Letters to the editor: Letter consisting of comments directly on publications of journal which are already published or introduces a specific issue of a general interest.
As Journal of Metabolic Disorders and Diabetes follows the Creative Commons Attribution License and scholars open access publishing policies, readers can freely access the published articles through online and JMDD will be kept up to date with latest advances in the field of Metabolic Disorders and Diabetes. All published articles will be assigned with unique Digital Objective Identifier provided by Cross Ref.